Evidence map›Paper›PMID 34578452›Full record

ArticleViruses2021

Multiple Occurrences of a 168-Nucleotide Deletion in SARS-CoV-2 ORF8, Unnoticed by Standard Amplicon Sequencing and Variant Calling Pipelines.

David Brandt, Marina Simunovic, Tobias Busche, Markus Haak, Peter Belmann, Sebastian Jünemann, Tizian Schulz, Levin Joe Klages, Svenja Vinke, Michael Beckstette and 4 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. A 336-nucleotide in-frame deletion in ORF7a gene of SARS-CoV-2 identified in genomic surveillance by next-generation sequencing.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

David BrandtCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0002-8859-8646
Marina SimunovicCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0002-7635-250X
Tobias BuscheCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
Markus HaakCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0003-0819-1182
Peter BelmannCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0002-1294-2869
Sebastian JünemannCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
Tizian SchulzCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
Levin Joe KlagesCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0003-1634-3705
Svenja VinkeCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
Michael BeckstetteCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
Ehmke PohlDepartment of Biosciences, Durham University, Durham DH1 3LE, UK.
Christiane SchererEvangelisches Klinikum Bethel, Institut für Laboratoriumsmedizin, Mikrobiologie und Hygiene, 33617 Bielefeld, Germany.
Alexander SczyrbaCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0002-4405-3847
Jörn KalinowskiCenter for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
Bielefeld University · DEDurham University · GB

Funding

Bundesministerium für Bildung und Forschung 031A532BBundesministerium für Bildung und Forschung 031A533A
6 · The paper itself

Abstract

Genomic surveillance of the SARS-CoV-2 pandemic is crucial and mainly achieved by amplicon sequencing protocols. Overlapping tiled-amplicons are generated to establish contiguous SARS-CoV-2 genome sequences, which enable the precise resolution of infection chains and outbreaks. We investigated a SARS-CoV-2 outbreak in a local hospital and used nanopore sequencing with a modified ARTIC protocol employing 1200 bp long amplicons. We detected a long deletion of 168 nucleotides in the ORF8 gene in 76 samples from the hospital outbreak. This deletion is difficult to identify with the classical amplicon sequencing procedures since it removes two amplicon primer-binding sites. We analyzed public SARS-CoV-2 sequences and sequencing read data from ENA and identified the same deletion in over 100 genomes belonging to different lineages of SARS-CoV-2, pointing to a mutation hotspot or to positive selection. In almost all cases, the deletion was not represented in the virus genome sequence after consensus building. Additionally, further database searches point to other deletions in the ORF8 coding region that have never been reported by the standard data analysis pipelines. These findings and the fact that ORF8 is especially prone to deletions, make a clear case for the urgent necessity of public availability of the raw data for this and other large deletions that might change the physiology of the virus towards endemism.

Indexed as

Genes, ViralSequence DeletionCOVID-19Genetic VariationHumansNanopore SequencingOpen Reading FramesSARS-CoV-2Sequence Analysis, RNAWhole Genome Sequencinggenomic surveillancenanopore sequencingORF8 deletionSARS-CoV-2viral genomics

Identifiers

PMID34578452
PMCPMC8518987
OpenAlexW3200430698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.